nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—colon cancer—breast cancer	0.215	1	CtDrD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—breast cancer	0.166	0.515	CiPCiCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—breast cancer	0.156	0.485	CiPCiCtD
Capecitabine—CDA—breast cancer	0.0963	0.522	CbGaD
Capecitabine—DPYD—breast cancer	0.0568	0.308	CbGaD
Capecitabine—DPYD—Fluorouracil—breast cancer	0.0377	0.222	CbGbCtD
Capecitabine—CDA—Gemcitabine—breast cancer	0.035	0.206	CbGbCtD
Capecitabine—TYMS—breast cancer	0.0314	0.17	CbGaD
Capecitabine—TYMP—Fluorouracil—breast cancer	0.0251	0.147	CbGbCtD
Capecitabine—TYMS—Gemcitabine—breast cancer	0.0156	0.0916	CbGbCtD
Capecitabine—CES1—Tamoxifen—breast cancer	0.0141	0.083	CbGbCtD
Capecitabine—TYMS—Fluorouracil—breast cancer	0.0133	0.0784	CbGbCtD
Capecitabine—CES1—Irinotecan—breast cancer	0.0108	0.0637	CbGbCtD
Capecitabine—TYMS—Methotrexate—breast cancer	0.00736	0.0432	CbGbCtD
Capecitabine—CYP2C9—Anastrozole—breast cancer	0.00429	0.0252	CbGbCtD
Capecitabine—CYP2C9—Idarubicin—breast cancer	0.00325	0.0191	CbGbCtD
Capecitabine—CYP2C9—Tamoxifen—breast cancer	0.00143	0.00842	CbGbCtD
Capecitabine—CYP2C9—Paclitaxel—breast cancer	0.00112	0.00655	CbGbCtD
Capecitabine—DPYD—mammary gland—breast cancer	0.00108	0.0814	CbGeAlD
Capecitabine—CYP2C9—Fluorouracil—breast cancer	0.00106	0.0062	CbGbCtD
Capecitabine—TYMP—mammary gland—breast cancer	0.000628	0.0472	CbGeAlD
Capecitabine—CDA—endometrium—breast cancer	0.000521	0.0391	CbGeAlD
Capecitabine—TYMP—nipple—breast cancer	0.00052	0.039	CbGeAlD
Capecitabine—DPYD—uterus—breast cancer	0.000499	0.0375	CbGeAlD
Capecitabine—DPYD—adipose tissue—breast cancer	0.000488	0.0366	CbGeAlD
Capecitabine—CDA—adipose tissue—breast cancer	0.00047	0.0352	CbGeAlD
Capecitabine—DPYD—adrenal gland—breast cancer	0.000438	0.0329	CbGeAlD
Capecitabine—DPYD—bone marrow—breast cancer	0.000424	0.0318	CbGeAlD
Capecitabine—CDA—adrenal gland—breast cancer	0.000421	0.0316	CbGeAlD
Capecitabine—DPYD—female gonad—breast cancer	0.000408	0.0306	CbGeAlD
Capecitabine—CDA—bone marrow—breast cancer	0.000408	0.0306	CbGeAlD
Capecitabine—CDA—endocrine gland—breast cancer	0.000365	0.0274	CbGeAlD
Capecitabine—TYMP—endometrium—breast cancer	0.000314	0.0236	CbGeAlD
Capecitabine—TYMP—uterus—breast cancer	0.000289	0.0217	CbGeAlD
Capecitabine—TYMS—skin of body—breast cancer	0.000286	0.0214	CbGeAlD
Capecitabine—TYMP—pituitary gland—breast cancer	0.000284	0.0213	CbGeAlD
Capecitabine—TYMP—adipose tissue—breast cancer	0.000283	0.0212	CbGeAlD
Capecitabine—TYMS—endometrium—breast cancer	0.000269	0.0202	CbGeAlD
Capecitabine—DPYD—lymph node—breast cancer	0.000262	0.0197	CbGeAlD
Capecitabine—TYMP—female reproductive system—breast cancer	0.00026	0.0195	CbGeAlD
Capecitabine—TYMP—adrenal gland—breast cancer	0.000254	0.019	CbGeAlD
Capecitabine—CDA—lymph node—breast cancer	0.000253	0.019	CbGeAlD
Capecitabine—TYMP—bone marrow—breast cancer	0.000245	0.0184	CbGeAlD
Capecitabine—CES1—adipose tissue—breast cancer	0.000244	0.0183	CbGeAlD
Capecitabine—TYMS—adipose tissue—breast cancer	0.000243	0.0182	CbGeAlD
Capecitabine—TYMP—female gonad—breast cancer	0.000237	0.0178	CbGeAlD
Capecitabine—CYP2C9—mammary gland—breast cancer	0.000235	0.0177	CbGeAlD
Capecitabine—CES1—female reproductive system—breast cancer	0.000224	0.0168	CbGeAlD
Capecitabine—TYMS—female reproductive system—breast cancer	0.000223	0.0167	CbGeAlD
Capecitabine—TYMP—endocrine gland—breast cancer	0.00022	0.0165	CbGeAlD
Capecitabine—CES1—adrenal gland—breast cancer	0.000219	0.0164	CbGeAlD
Capecitabine—TYMS—adrenal gland—breast cancer	0.000218	0.0163	CbGeAlD
Capecitabine—TYMS—bone marrow—breast cancer	0.000211	0.0158	CbGeAlD
Capecitabine—CES1—female gonad—breast cancer	0.000204	0.0153	CbGeAlD
Capecitabine—TYMS—female gonad—breast cancer	0.000203	0.0152	CbGeAlD
Capecitabine—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000191	0.226	CbGdCrCtD
Capecitabine—CES1—endocrine gland—breast cancer	0.00019	0.0143	CbGeAlD
Capecitabine—TYMS—endocrine gland—breast cancer	0.000189	0.0142	CbGeAlD
Capecitabine—TYMS—Gefitinib—Lapatinib—breast cancer	0.000187	0.221	CbGdCrCtD
Capecitabine—TYMP—lymph node—breast cancer	0.000152	0.0114	CbGeAlD
Capecitabine—CES1—lymph node—breast cancer	0.000131	0.00985	CbGeAlD
Capecitabine—TYMS—lymph node—breast cancer	0.00013	0.00979	CbGeAlD
Capecitabine—CYP2C9—female reproductive system—breast cancer	9.74e-05	0.00731	CbGeAlD
Capecitabine—TYMS—Paclitaxel—Docetaxel—breast cancer	9.53e-05	0.113	CbGdCrCtD
Capecitabine—CYP2C9—endocrine gland—breast cancer	8.24e-05	0.00618	CbGeAlD
Capecitabine—TYMS—Vincristine—Vinorelbine—breast cancer	6.55e-05	0.0775	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vinblastine—breast cancer	6.12e-05	0.0725	CbGdCrCtD
Capecitabine—TYMS—Vinblastine—Vinorelbine—breast cancer	5.27e-05	0.0623	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinblastine—breast cancer	5.24e-05	0.062	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	4.22e-05	0.0499	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	4.12e-05	0.0487	CbGdCrCtD
Capecitabine—TYMS—Danazol—Fluoxymesterone—breast cancer	3.19e-05	0.0377	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Gemcitabine—breast cancer	2.47e-05	0.0292	CbGdCrCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1B1—breast cancer	5.07e-06	0.00016	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—breast cancer	5e-06	0.000158	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—breast cancer	5e-06	0.000157	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA1—breast cancer	4.99e-06	0.000157	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH1—breast cancer	4.99e-06	0.000157	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	4.99e-06	0.000157	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—breast cancer	4.96e-06	0.000156	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	4.95e-06	0.000156	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NAT2—breast cancer	4.93e-06	0.000155	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCB1—breast cancer	4.91e-06	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—NCOA1—breast cancer	4.9e-06	0.000154	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CAV1—breast cancer	4.86e-06	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP19A1—breast cancer	4.83e-06	0.000152	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TYMS—breast cancer	4.82e-06	0.000152	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP19A1—breast cancer	4.76e-06	0.00015	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NCOR1—breast cancer	4.76e-06	0.00015	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—breast cancer	4.76e-06	0.00015	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PLA2G4A—breast cancer	4.76e-06	0.00015	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK2—breast cancer	4.73e-06	0.000149	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	4.66e-06	0.000147	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	4.66e-06	0.000147	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPX1—breast cancer	4.56e-06	0.000144	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.55e-06	0.000143	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1A1—breast cancer	4.52e-06	0.000142	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—ATM—breast cancer	4.49e-06	0.000142	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—COMT—breast cancer	4.49e-06	0.000141	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ERCC2—breast cancer	4.48e-06	0.000141	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK4—breast cancer	4.47e-06	0.000141	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—breast cancer	4.47e-06	0.000141	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—COMT—breast cancer	4.43e-06	0.00014	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—breast cancer	4.43e-06	0.000139	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HADHB—breast cancer	4.42e-06	0.000139	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—breast cancer	4.41e-06	0.000139	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.4e-06	0.000138	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CD—breast cancer	4.36e-06	0.000137	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—breast cancer	4.35e-06	0.000137	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MED12—breast cancer	4.33e-06	0.000136	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—DPYD—breast cancer	4.33e-06	0.000136	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—breast cancer	4.31e-06	0.000136	CbGpPWpGaD
Capecitabine—Paraesthesia—Docetaxel—breast cancer	4.29e-06	6.95e-05	CcSEcCtD
Capecitabine—Erythema multiforme—Epirubicin—breast cancer	4.29e-06	6.94e-05	CcSEcCtD
Capecitabine—Alopecia—Methotrexate—breast cancer	4.29e-06	6.94e-05	CcSEcCtD
Capecitabine—Vomiting—Gemcitabine—breast cancer	4.28e-06	6.93e-05	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—breast cancer	4.28e-06	6.92e-05	CcSEcCtD
Capecitabine—Dyspnoea—Docetaxel—breast cancer	4.26e-06	6.9e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ALDOA—breast cancer	4.26e-06	0.000134	CbGpPWpGaD
Capecitabine—Mental disorder—Methotrexate—breast cancer	4.25e-06	6.88e-05	CcSEcCtD
Capecitabine—Rash—Gemcitabine—breast cancer	4.25e-06	6.87e-05	CcSEcCtD
Capecitabine—Dermatitis—Gemcitabine—breast cancer	4.24e-06	6.87e-05	CcSEcCtD
Capecitabine—Eye disorder—Epirubicin—breast cancer	4.24e-06	6.86e-05	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—breast cancer	4.23e-06	6.85e-05	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—breast cancer	4.22e-06	6.83e-05	CcSEcCtD
Capecitabine—Erythema—Methotrexate—breast cancer	4.22e-06	6.83e-05	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—breast cancer	4.22e-06	0.000133	CbGpPWpGaD
Capecitabine—Haemoglobin—Doxorubicin—breast cancer	4.22e-06	6.83e-05	CcSEcCtD
Capecitabine—Headache—Gemcitabine—breast cancer	4.22e-06	6.83e-05	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—breast cancer	4.21e-06	6.82e-05	CcSEcCtD
Capecitabine—Flushing—Epirubicin—breast cancer	4.21e-06	6.82e-05	CcSEcCtD
Capecitabine—Vomiting—Fluorouracil—breast cancer	4.21e-06	6.81e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—MTHFR—breast cancer	4.21e-06	0.000133	CbGpPWpGaD
Capecitabine—Rhinitis—Doxorubicin—breast cancer	4.21e-06	6.81e-05	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—breast cancer	4.21e-06	6.81e-05	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—breast cancer	4.2e-06	6.8e-05	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—breast cancer	4.2e-06	6.8e-05	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—breast cancer	4.18e-06	6.76e-05	CcSEcCtD
Capecitabine—Rash—Fluorouracil—breast cancer	4.18e-06	6.76e-05	CcSEcCtD
Capecitabine—Dermatitis—Fluorouracil—breast cancer	4.17e-06	6.75e-05	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—breast cancer	4.17e-06	6.74e-05	CcSEcCtD
Capecitabine—Decreased appetite—Docetaxel—breast cancer	4.16e-06	6.72e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Paclitaxel—breast cancer	4.16e-06	6.72e-05	CcSEcCtD
Capecitabine—Headache—Fluorouracil—breast cancer	4.15e-06	6.71e-05	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—breast cancer	4.15e-06	6.71e-05	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—breast cancer	4.14e-06	6.69e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—NCOA3—breast cancer	4.14e-06	0.00013	CbGpPWpGaD
Capecitabine—Dysgeusia—Methotrexate—breast cancer	4.13e-06	6.69e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Docetaxel—breast cancer	4.13e-06	6.68e-05	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—breast cancer	4.13e-06	6.68e-05	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—breast cancer	4.12e-06	6.67e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—NOS3—breast cancer	4.12e-06	0.00013	CbGpPWpGaD
Capecitabine—Angiopathy—Epirubicin—breast cancer	4.12e-06	6.66e-05	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—breast cancer	4.12e-06	6.66e-05	CcSEcCtD
Capecitabine—Nausea—Mitoxantrone—breast cancer	4.11e-06	6.65e-05	CcSEcCtD
Capecitabine—Nausea—Irinotecan—breast cancer	4.11e-06	6.65e-05	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—breast cancer	4.11e-06	0.000129	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A2—breast cancer	4.11e-06	0.000129	CbGpPWpGaD
Capecitabine—Immune system disorder—Epirubicin—breast cancer	4.1e-06	6.63e-05	CcSEcCtD
Capecitabine—Mediastinal disorder—Epirubicin—breast cancer	4.09e-06	6.62e-05	CcSEcCtD
Capecitabine—Constipation—Docetaxel—breast cancer	4.09e-06	6.62e-05	CcSEcCtD
Capecitabine—Pain—Docetaxel—breast cancer	4.09e-06	6.62e-05	CcSEcCtD
Capecitabine—Back pain—Methotrexate—breast cancer	4.08e-06	6.61e-05	CcSEcCtD
Capecitabine—Chills—Epirubicin—breast cancer	4.07e-06	6.59e-05	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—breast cancer	4.05e-06	6.56e-05	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—breast cancer	4.05e-06	0.000128	CbGpPWpGaD
Capecitabine—Visual impairment—Doxorubicin—breast cancer	4.05e-06	6.55e-05	CcSEcCtD
Capecitabine—Asthenia—Paclitaxel—breast cancer	4.05e-06	6.55e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	4.04e-06	0.000127	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CPT1A—breast cancer	4.02e-06	0.000127	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTR—breast cancer	4.02e-06	0.000127	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG2—breast cancer	4.02e-06	0.000127	CbGpPWpGaD
Capecitabine—Alopecia—Epirubicin—breast cancer	4.01e-06	6.49e-05	CcSEcCtD
Capecitabine—Nausea—Gemcitabine—breast cancer	4e-06	6.48e-05	CcSEcCtD
Capecitabine—Pruritus—Paclitaxel—breast cancer	3.99e-06	6.46e-05	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—breast cancer	3.98e-06	6.44e-05	CcSEcCtD
Capecitabine—Mental disorder—Epirubicin—breast cancer	3.98e-06	6.43e-05	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—breast cancer	3.97e-06	6.43e-05	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—breast cancer	3.95e-06	6.39e-05	CcSEcCtD
Capecitabine—Erythema—Epirubicin—breast cancer	3.95e-06	6.39e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—HPGDS—breast cancer	3.95e-06	0.000124	CbGpPWpGaD
Capecitabine—Feeling abnormal—Docetaxel—breast cancer	3.94e-06	6.38e-05	CcSEcCtD
Capecitabine—Nausea—Fluorouracil—breast cancer	3.93e-06	6.37e-05	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—breast cancer	3.92e-06	6.35e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—HBA1—breast cancer	3.92e-06	0.000123	CbGpPWpGaD
Capecitabine—Ill-defined disorder—Methotrexate—breast cancer	3.92e-06	6.34e-05	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—breast cancer	3.92e-06	6.34e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—breast cancer	3.91e-06	6.33e-05	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—breast cancer	3.9e-06	6.31e-05	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—breast cancer	3.9e-06	6.31e-05	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—breast cancer	3.9e-06	6.31e-05	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—breast cancer	3.89e-06	0.000123	CbGpPWpGaD
Capecitabine—Flatulence—Epirubicin—breast cancer	3.89e-06	6.3e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—RB1—breast cancer	3.89e-06	0.000123	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—breast cancer	3.89e-06	0.000123	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAV1—breast cancer	3.88e-06	0.000122	CbGpPWpGaD
Capecitabine—Dysgeusia—Epirubicin—breast cancer	3.87e-06	6.26e-05	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—IL6—breast cancer	3.86e-06	0.000122	CbGpPWpGaD
Capecitabine—Diarrhoea—Paclitaxel—breast cancer	3.86e-06	6.24e-05	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—breast cancer	3.84e-06	0.000121	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—breast cancer	3.84e-06	0.000121	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—breast cancer	3.83e-06	0.000121	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ACHE—breast cancer	3.83e-06	0.000121	CbGpPWpGaD
Capecitabine—Back pain—Epirubicin—breast cancer	3.82e-06	6.18e-05	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—breast cancer	3.81e-06	6.17e-05	CcSEcCtD
Capecitabine—Malaise—Methotrexate—breast cancer	3.81e-06	6.16e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CB—breast cancer	3.8e-06	0.00012	CbGpPWpGaD
Capecitabine—Muscle spasms—Epirubicin—breast cancer	3.8e-06	6.15e-05	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—breast cancer	3.79e-06	6.14e-05	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—breast cancer	3.79e-06	6.14e-05	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—breast cancer	3.79e-06	6.12e-05	CcSEcCtD
Capecitabine—Abdominal pain—Docetaxel—breast cancer	3.78e-06	6.12e-05	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—breast cancer	3.78e-06	6.12e-05	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—breast cancer	3.78e-06	6.12e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTGS2—breast cancer	3.77e-06	0.000119	CbGpPWpGaD
Capecitabine—Chills—Doxorubicin—breast cancer	3.77e-06	6.1e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	3.76e-06	0.000118	CbGpPWpGaD
Capecitabine—Arrhythmia—Doxorubicin—breast cancer	3.75e-06	6.07e-05	CcSEcCtD
Capecitabine—Dizziness—Paclitaxel—breast cancer	3.73e-06	6.04e-05	CcSEcCtD
Capecitabine—Vision blurred—Epirubicin—breast cancer	3.72e-06	6.03e-05	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.71e-06	0.000117	CbGpPWpGaD
Capecitabine—Alopecia—Doxorubicin—breast cancer	3.71e-06	6.01e-05	CcSEcCtD
Capecitabine—Cough—Methotrexate—breast cancer	3.68e-06	5.96e-05	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—breast cancer	3.68e-06	5.95e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—NOS3—breast cancer	3.67e-06	0.000116	CbGpPWpGaD
Capecitabine—Ill-defined disorder—Epirubicin—breast cancer	3.67e-06	5.93e-05	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—breast cancer	3.66e-06	5.92e-05	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—breast cancer	3.66e-06	5.92e-05	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—breast cancer	3.65e-06	5.91e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	3.64e-06	0.000115	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP17A1—breast cancer	3.62e-06	0.000114	CbGpPWpGaD
Capecitabine—Flatulence—Doxorubicin—breast cancer	3.6e-06	5.83e-05	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—breast cancer	3.59e-06	5.82e-05	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—breast cancer	3.59e-06	5.82e-05	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—breast cancer	3.59e-06	5.82e-05	CcSEcCtD
Capecitabine—Vomiting—Paclitaxel—breast cancer	3.59e-06	5.8e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PTGS1—breast cancer	3.59e-06	0.000113	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ENO1—breast cancer	3.59e-06	0.000113	CbGpPWpGaD
Capecitabine—Dysgeusia—Doxorubicin—breast cancer	3.58e-06	5.79e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.57e-06	5.78e-05	CcSEcCtD
Capecitabine—Malaise—Epirubicin—breast cancer	3.56e-06	5.77e-05	CcSEcCtD
Capecitabine—Rash—Paclitaxel—breast cancer	3.56e-06	5.75e-05	CcSEcCtD
Capecitabine—Dermatitis—Paclitaxel—breast cancer	3.55e-06	5.75e-05	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—breast cancer	3.55e-06	5.75e-05	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—breast cancer	3.55e-06	5.74e-05	CcSEcCtD
Capecitabine—Syncope—Epirubicin—breast cancer	3.54e-06	5.73e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CG—breast cancer	3.54e-06	0.000111	CbGpPWpGaD
Capecitabine—Leukopenia—Epirubicin—breast cancer	3.54e-06	5.72e-05	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—breast cancer	3.54e-06	5.72e-05	CcSEcCtD
Capecitabine—Headache—Paclitaxel—breast cancer	3.53e-06	5.72e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Docetaxel—breast cancer	3.52e-06	5.7e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP2D6—breast cancer	3.52e-06	0.000111	CbGpPWpGaD
Capecitabine—Muscle spasms—Doxorubicin—breast cancer	3.52e-06	5.69e-05	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—breast cancer	3.49e-06	5.65e-05	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—breast cancer	3.47e-06	5.62e-05	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—breast cancer	3.47e-06	5.62e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—NCOA2—breast cancer	3.45e-06	0.000109	CbGpPWpGaD
Capecitabine—Cough—Epirubicin—breast cancer	3.45e-06	5.58e-05	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—breast cancer	3.45e-06	5.58e-05	CcSEcCtD
Capecitabine—Asthenia—Docetaxel—breast cancer	3.43e-06	5.55e-05	CcSEcCtD
Capecitabine—Infection—Methotrexate—breast cancer	3.42e-06	5.54e-05	CcSEcCtD
Capecitabine—Hypertension—Epirubicin—breast cancer	3.41e-06	5.52e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—breast cancer	3.39e-06	5.49e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CB—breast cancer	3.39e-06	0.000107	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—breast cancer	3.39e-06	0.000107	CbGpPWpGaD
Capecitabine—Pruritus—Docetaxel—breast cancer	3.38e-06	5.47e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—breast cancer	3.38e-06	5.47e-05	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—breast cancer	3.38e-06	5.47e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—breast cancer	3.37e-06	5.46e-05	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—breast cancer	3.36e-06	5.44e-05	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—breast cancer	3.36e-06	5.44e-05	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—breast cancer	3.36e-06	5.44e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PTGS2—breast cancer	3.36e-06	0.000106	CbGpPWpGaD
Capecitabine—Anxiety—Epirubicin—breast cancer	3.35e-06	5.42e-05	CcSEcCtD
Capecitabine—Nausea—Paclitaxel—breast cancer	3.35e-06	5.42e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	3.35e-06	0.000105	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FASN—breast cancer	3.35e-06	0.000105	CbGpPWpGaD
Capecitabine—Skin disorder—Methotrexate—breast cancer	3.35e-06	5.42e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.34e-06	5.41e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—BCHE—breast cancer	3.33e-06	0.000105	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Methotrexate—breast cancer	3.33e-06	5.39e-05	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—breast cancer	3.32e-06	5.38e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MDM2—breast cancer	3.32e-06	0.000104	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	3.31e-06	0.000104	CbGpPWpGaD
Capecitabine—Malaise—Doxorubicin—breast cancer	3.3e-06	5.33e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC5A5—breast cancer	3.29e-06	0.000104	CbGpPWpGaD
Capecitabine—Dry mouth—Epirubicin—breast cancer	3.29e-06	5.32e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTEN—breast cancer	3.29e-06	0.000104	CbGpPWpGaD
Capecitabine—Vertigo—Doxorubicin—breast cancer	3.28e-06	5.32e-05	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—breast cancer	3.28e-06	5.31e-05	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—breast cancer	3.28e-06	5.31e-05	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—breast cancer	3.27e-06	5.3e-05	CcSEcCtD
Capecitabine—Diarrhoea—Docetaxel—breast cancer	3.27e-06	5.29e-05	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—breast cancer	3.25e-06	5.26e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—breast cancer	3.23e-06	0.000102	CbGpPWpGaD
Capecitabine—Palpitations—Doxorubicin—breast cancer	3.23e-06	5.23e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	3.23e-06	0.000102	CbGpPWpGaD
Capecitabine—Oedema—Epirubicin—breast cancer	3.22e-06	5.22e-05	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—breast cancer	3.22e-06	5.21e-05	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—breast cancer	3.21e-06	5.2e-05	CcSEcCtD
Capecitabine—Infection—Epirubicin—breast cancer	3.2e-06	5.18e-05	CcSEcCtD
Capecitabine—Cough—Doxorubicin—breast cancer	3.19e-06	5.16e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—NQO1—breast cancer	3.18e-06	0.0001	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC2A1—breast cancer	3.18e-06	0.0001	CbGpPWpGaD
Capecitabine—Shock—Epirubicin—breast cancer	3.17e-06	5.13e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—breast cancer	3.16e-06	5.12e-05	CcSEcCtD
Capecitabine—Dizziness—Docetaxel—breast cancer	3.16e-06	5.12e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—breast cancer	3.16e-06	5.11e-05	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—breast cancer	3.16e-06	5.11e-05	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—breast cancer	3.15e-06	5.09e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.14e-06	5.08e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—SYNJ2—breast cancer	3.13e-06	9.87e-05	CbGpPWpGaD
Capecitabine—Skin disorder—Epirubicin—breast cancer	3.13e-06	5.07e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—breast cancer	3.13e-06	9.85e-05	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Epirubicin—breast cancer	3.12e-06	5.04e-05	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—breast cancer	3.12e-06	5.04e-05	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—breast cancer	3.11e-06	5.04e-05	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—breast cancer	3.11e-06	5.04e-05	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—breast cancer	3.11e-06	5.04e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CD—breast cancer	3.11e-06	9.79e-05	CbGpPWpGaD
Capecitabine—Anxiety—Doxorubicin—breast cancer	3.1e-06	5.02e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP3A4—breast cancer	3.1e-06	9.77e-05	CbGpPWpGaD
Capecitabine—Paraesthesia—Methotrexate—breast cancer	3.09e-06	5.01e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.09e-06	5e-05	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—breast cancer	3.08e-06	4.98e-05	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—breast cancer	3.07e-06	4.97e-05	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—breast cancer	3.07e-06	4.97e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—ALB—breast cancer	3.07e-06	9.67e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1B1—breast cancer	3.05e-06	9.6e-05	CbGpPWpGaD
Capecitabine—Dry mouth—Doxorubicin—breast cancer	3.04e-06	4.93e-05	CcSEcCtD
Capecitabine—Vomiting—Docetaxel—breast cancer	3.04e-06	4.92e-05	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—breast cancer	3.03e-06	4.91e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN1B—breast cancer	3.03e-06	9.54e-05	CbGpPWpGaD
Capecitabine—Rash—Docetaxel—breast cancer	3.01e-06	4.88e-05	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—breast cancer	3.01e-06	4.88e-05	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—breast cancer	3.01e-06	4.87e-05	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—breast cancer	3.01e-06	4.87e-05	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—breast cancer	3e-06	4.85e-05	CcSEcCtD
Capecitabine—Headache—Docetaxel—breast cancer	3e-06	4.85e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—HSP90AA1—breast cancer	2.99e-06	9.42e-05	CbGpPWpGaD
Capecitabine—Oedema—Doxorubicin—breast cancer	2.98e-06	4.83e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—breast cancer	2.97e-06	4.81e-05	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—breast cancer	2.97e-06	4.81e-05	CcSEcCtD
Capecitabine—Infection—Doxorubicin—breast cancer	2.96e-06	4.8e-05	CcSEcCtD
Capecitabine—Pain—Methotrexate—breast cancer	2.95e-06	4.77e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.94e-06	4.75e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—NOS3—breast cancer	2.94e-06	9.25e-05	CbGpPWpGaD
Capecitabine—Shock—Doxorubicin—breast cancer	2.94e-06	4.75e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PTEN—breast cancer	2.93e-06	9.23e-05	CbGpPWpGaD
Capecitabine—Nervous system disorder—Doxorubicin—breast cancer	2.93e-06	4.73e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—breast cancer	2.92e-06	4.73e-05	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—breast cancer	2.92e-06	4.72e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NDUFS3—breast cancer	2.91e-06	9.17e-05	CbGpPWpGaD
Capecitabine—Tachycardia—Doxorubicin—breast cancer	2.91e-06	4.71e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—NCOA1—breast cancer	2.91e-06	9.16e-05	CbGpPWpGaD
Capecitabine—Skin disorder—Doxorubicin—breast cancer	2.9e-06	4.69e-05	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—breast cancer	2.9e-06	4.69e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCND1—breast cancer	2.89e-06	9.1e-05	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Doxorubicin—breast cancer	2.88e-06	4.67e-05	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—breast cancer	2.88e-06	4.65e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP19A1—breast cancer	2.87e-06	9.03e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—STK11—breast cancer	2.87e-06	9.03e-05	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—breast cancer	2.84e-06	4.6e-05	CcSEcCtD
Capecitabine—Nausea—Docetaxel—breast cancer	2.84e-06	4.6e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—breast cancer	2.84e-06	4.59e-05	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—breast cancer	2.84e-06	4.59e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—breast cancer	2.82e-06	4.56e-05	CcSEcCtD
Capecitabine—Decreased appetite—Epirubicin—breast cancer	2.8e-06	4.54e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.8e-06	8.82e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—breast cancer	2.8e-06	8.8e-05	CbGpPWpGaD
Capecitabine—Hypotension—Doxorubicin—breast cancer	2.79e-06	4.51e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—breast cancer	2.78e-06	4.5e-05	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—breast cancer	2.78e-06	4.5e-05	CcSEcCtD
Capecitabine—Pain—Epirubicin—breast cancer	2.76e-06	4.46e-05	CcSEcCtD
Capecitabine—Constipation—Epirubicin—breast cancer	2.76e-06	4.46e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CHST9—breast cancer	2.74e-06	8.62e-05	CbGpPWpGaD
Capecitabine—Urticaria—Methotrexate—breast cancer	2.74e-06	4.43e-05	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—breast cancer	2.72e-06	4.41e-05	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—breast cancer	2.72e-06	4.41e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.72e-06	4.4e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CB—breast cancer	2.71e-06	8.54e-05	CbGpPWpGaD
Capecitabine—Insomnia—Doxorubicin—breast cancer	2.7e-06	4.37e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTGS2—breast cancer	2.69e-06	8.46e-05	CbGpPWpGaD
Capecitabine—Paraesthesia—Doxorubicin—breast cancer	2.68e-06	4.34e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.68e-06	8.43e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—breast cancer	2.67e-06	8.39e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—COMT—breast cancer	2.66e-06	8.39e-05	CbGpPWpGaD
Capecitabine—Dyspnoea—Doxorubicin—breast cancer	2.66e-06	4.3e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—breast cancer	2.66e-06	4.3e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTP1—breast cancer	2.65e-06	8.35e-05	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Epirubicin—breast cancer	2.64e-06	4.27e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—breast cancer	2.63e-06	4.25e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—HMOX1—breast cancer	2.62e-06	8.24e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ITPR1—breast cancer	2.61e-06	8.22e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.6e-06	8.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COX11—breast cancer	2.6e-06	8.18e-05	CbGpPWpGaD
Capecitabine—Decreased appetite—Doxorubicin—breast cancer	2.59e-06	4.2e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—breast cancer	2.59e-06	8.16e-05	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.58e-06	4.17e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—breast cancer	2.57e-06	4.16e-05	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—breast cancer	2.56e-06	4.15e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.55e-06	8.04e-05	CbGpPWpGaD
Capecitabine—Pain—Doxorubicin—breast cancer	2.55e-06	4.13e-05	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—breast cancer	2.55e-06	4.13e-05	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—breast cancer	2.55e-06	4.12e-05	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—breast cancer	2.55e-06	4.12e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—breast cancer	2.54e-06	4.11e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ABCB1—breast cancer	2.51e-06	7.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.48e-06	7.8e-05	CbGpPWpGaD
Capecitabine—Asthenia—Methotrexate—breast cancer	2.47e-06	4e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—breast cancer	2.46e-06	3.98e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—breast cancer	2.44e-06	3.95e-05	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—breast cancer	2.44e-06	3.94e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTM1—breast cancer	2.44e-06	7.68e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOR1—breast cancer	2.44e-06	7.68e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLA2G4A—breast cancer	2.44e-06	7.68e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK3—breast cancer	2.38e-06	7.51e-05	CbGpPWpGaD
Capecitabine—Hypersensitivity—Epirubicin—breast cancer	2.38e-06	3.84e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CDA—breast cancer	2.37e-06	7.48e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SHMT1—breast cancer	2.37e-06	7.48e-05	CbGpPWpGaD
Capecitabine—Urticaria—Doxorubicin—breast cancer	2.37e-06	3.84e-05	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—breast cancer	2.36e-06	3.82e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—breast cancer	2.36e-06	3.82e-05	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—breast cancer	2.36e-06	3.82e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.34e-06	7.38e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—breast cancer	2.34e-06	7.38e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—breast cancer	2.33e-06	7.35e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.32e-06	7.31e-05	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—breast cancer	2.32e-06	7.3e-05	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—breast cancer	2.32e-06	7.3e-05	CbGpPWpGaD
Capecitabine—Asthenia—Epirubicin—breast cancer	2.31e-06	3.74e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP1A1—breast cancer	2.31e-06	7.28e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ERCC2—breast cancer	2.29e-06	7.22e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLCO1B1—breast cancer	2.29e-06	7.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A5—breast cancer	2.29e-06	7.2e-05	CbGpPWpGaD
Capecitabine—Pruritus—Epirubicin—breast cancer	2.28e-06	3.69e-05	CcSEcCtD
Capecitabine—Dizziness—Methotrexate—breast cancer	2.28e-06	3.69e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.23e-06	7.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APRT—breast cancer	2.21e-06	6.95e-05	CbGpPWpGaD
Capecitabine—Diarrhoea—Epirubicin—breast cancer	2.21e-06	3.57e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—breast cancer	2.2e-06	3.56e-05	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—breast cancer	2.19e-06	3.55e-05	CcSEcCtD
Capecitabine—Rash—Methotrexate—breast cancer	2.17e-06	3.52e-05	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—breast cancer	2.17e-06	3.51e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.17e-06	6.82e-05	CbGpPWpGaD
Capecitabine—Headache—Methotrexate—breast cancer	2.16e-06	3.49e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.16e-06	6.79e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—breast cancer	2.15e-06	6.78e-05	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—breast cancer	2.14e-06	3.46e-05	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—breast cancer	2.13e-06	3.45e-05	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—breast cancer	2.11e-06	3.42e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ANGPTL4—breast cancer	2.08e-06	6.54e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ESRRA—breast cancer	2.08e-06	6.54e-05	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—breast cancer	2.07e-06	6.51e-05	CbGpPWpGaD
Capecitabine—Vomiting—Epirubicin—breast cancer	2.05e-06	3.32e-05	CcSEcCtD
Capecitabine—Nausea—Methotrexate—breast cancer	2.05e-06	3.31e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—breast cancer	2.04e-06	3.3e-05	CcSEcCtD
Capecitabine—Rash—Epirubicin—breast cancer	2.03e-06	3.29e-05	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—breast cancer	2.03e-06	3.29e-05	CcSEcCtD
Capecitabine—Headache—Epirubicin—breast cancer	2.02e-06	3.27e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CAV1—breast cancer	1.99e-06	6.26e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.97e-06	6.21e-05	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—breast cancer	1.97e-06	3.19e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—GPI—breast cancer	1.97e-06	6.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HADHB—breast cancer	1.97e-06	6.2e-05	CbGpPWpGaD
Capecitabine—Nausea—Epirubicin—breast cancer	1.92e-06	3.1e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—breast cancer	1.9e-06	5.99e-05	CbGpPWpGaD
Capecitabine—Vomiting—Doxorubicin—breast cancer	1.9e-06	3.07e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—AKT1—breast cancer	1.89e-06	5.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.88e-06	5.93e-05	CbGpPWpGaD
Capecitabine—Rash—Doxorubicin—breast cancer	1.88e-06	3.04e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—breast cancer	1.88e-06	3.04e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.88e-06	5.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.88e-06	5.91e-05	CbGpPWpGaD
Capecitabine—Headache—Doxorubicin—breast cancer	1.87e-06	3.02e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.86e-06	5.84e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—breast cancer	1.81e-06	5.7e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UMPS—breast cancer	1.8e-06	5.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PHGDH—breast cancer	1.8e-06	5.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADSL—breast cancer	1.8e-06	5.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FHL2—breast cancer	1.8e-06	5.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NME1—breast cancer	1.8e-06	5.67e-05	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—breast cancer	1.77e-06	2.87e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—BRIP1—breast cancer	1.76e-06	5.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HPSE—breast cancer	1.76e-06	5.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LDHB—breast cancer	1.76e-06	5.56e-05	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—breast cancer	1.69e-06	5.32e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMMR—breast cancer	1.67e-06	5.27e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA3—breast cancer	1.67e-06	5.27e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCC1—breast cancer	1.67e-06	5.27e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—breast cancer	1.65e-06	5.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.62e-06	5.1e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—breast cancer	1.59e-06	5.01e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.58e-06	4.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.58e-06	4.97e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—breast cancer	1.57e-06	4.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA9—breast cancer	1.53e-06	4.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA4—breast cancer	1.53e-06	4.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.51e-06	4.76e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—breast cancer	1.5e-06	4.73e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.5e-06	4.71e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA2—breast cancer	1.49e-06	4.7e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX2—breast cancer	1.49e-06	4.7e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX4—breast cancer	1.47e-06	4.64e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SULT1A1—breast cancer	1.47e-06	4.64e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA1—breast cancer	1.44e-06	4.53e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—IDH1—breast cancer	1.44e-06	4.53e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAT2—breast cancer	1.42e-06	4.48e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—breast cancer	1.39e-06	4.37e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—breast cancer	1.37e-06	4.33e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—breast cancer	1.35e-06	4.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.29e-06	4.05e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DPYD—breast cancer	1.25e-06	3.93e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MED12—breast cancer	1.25e-06	3.93e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDOA—breast cancer	1.23e-06	3.87e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—breast cancer	1.2e-06	3.77e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA3—breast cancer	1.19e-06	3.75e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A2—breast cancer	1.18e-06	3.73e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.17e-06	3.69e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CPT1A—breast cancer	1.16e-06	3.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTR—breast cancer	1.16e-06	3.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG2—breast cancer	1.16e-06	3.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HPGDS—breast cancer	1.14e-06	3.58e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HBA1—breast cancer	1.13e-06	3.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—breast cancer	1.1e-06	3.47e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACHE—breast cancer	1.1e-06	3.47e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP17A1—breast cancer	1.04e-06	3.29e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS1—breast cancer	1.03e-06	3.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO1—breast cancer	1.03e-06	3.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.03e-06	3.24e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.02e-06	3.2e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2D6—breast cancer	1.01e-06	3.19e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA2—breast cancer	9.95e-07	3.13e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FASN—breast cancer	9.65e-07	3.04e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCHE—breast cancer	9.61e-07	3.03e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A5—breast cancer	9.49e-07	2.99e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A1—breast cancer	9.17e-07	2.89e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NQO1—breast cancer	9.17e-07	2.89e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.98e-07	2.83e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP3A4—breast cancer	8.94e-07	2.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.89e-07	2.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1B1—breast cancer	8.79e-07	2.77e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSP90AA1—breast cancer	8.62e-07	2.71e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—breast cancer	8.45e-07	2.66e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA1—breast cancer	8.38e-07	2.64e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—STK11—breast cancer	8.26e-07	2.6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP19A1—breast cancer	8.26e-07	2.6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.76e-07	2.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COMT—breast cancer	7.68e-07	2.42e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—breast cancer	7.64e-07	2.41e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—breast cancer	7.54e-07	2.37e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ITPR1—breast cancer	7.52e-07	2.37e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—breast cancer	7.24e-07	2.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—breast cancer	7.11e-07	2.24e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOR1—breast cancer	7.03e-07	2.21e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G4A—breast cancer	7.03e-07	2.21e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—breast cancer	7.03e-07	2.21e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—breast cancer	6.91e-07	2.17e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—breast cancer	6.73e-07	2.12e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—breast cancer	6.66e-07	2.1e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ERCC2—breast cancer	6.61e-07	2.08e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—breast cancer	6.21e-07	1.96e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAV1—breast cancer	5.73e-07	1.8e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.47e-07	1.72e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—breast cancer	5.22e-07	1.64e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—breast cancer	4.59e-07	1.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—breast cancer	4.53e-07	1.43e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—breast cancer	4.33e-07	1.36e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—breast cancer	4e-07	1.26e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—breast cancer	3.96e-07	1.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—breast cancer	3.45e-07	1.09e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—breast cancer	2.44e-07	7.67e-06	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—breast cancer	1.99e-07	6.27e-06	CbGpPWpGaD
